1. Home
  2. KALV vs ODV Comparison

KALV vs ODV Comparison

Compare KALV & ODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.68

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Osisko Development Corp.

ODV

Osisko Development Corp.

HOLD

Current Price

$3.00

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
ODV
Founded
N/A
2005
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
KALV
ODV
Price
$26.68
$3.00
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.60
N/A
AVG Volume (30 Days)
2.7M
1.6M
Earning Date
07-09-2026
08-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,000,000.00
N/A
Revenue This Year
$185.42
N/A
Revenue Next Year
$59.23
$2.70
P/E Ratio
N/A
N/A
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$1.60
52 Week High
$26.76
$4.80

Technical Indicators

Market Signals
Indicator
KALV
ODV
Relative Strength Index (RSI) 75.31 37.57
Support Level $14.43 $2.82
Resistance Level N/A $3.22
Average True Range (ATR) 0.97 0.17
MACD 0.53 -0.04
Stochastic Oscillator 99.01 7.47

Price Performance

Historical Comparison
KALV
ODV

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About ODV Osisko Development Corp.

Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration, and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico, and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation, and development activities of its projects.

Share on Social Networks: